Report Feature
High Potency API Market Trends and Forecast
The future of the global high potency API market looks promising with opportunities in the oncology, glaucoma, hormonal imbalance, and other therapeutic applications segment. The global high potency API market is expected to reach an estimated $38.1 billion by 2028 with a CAGR of 8.7% from 2023 to 2028. The major drivers for this market are growing demand for oncology drugs and antibody-drug conjugates, increasing demand for outsourcing HPAPIs, and growing focus on precision medicine.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
High Potency API Market by Segment
The study includes trends and forecast for the global high potency API market by type, type of synthesis, type of manufacturers, therapeutic application, and region, as follows:
High Potency API Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Innovative API Market
- Generic API Market
High Potency API Market by Type of Synthesis [Value ($B) Shipment Analysis from 2017 to 2028]:
- Synthetic API Market
- Biotech API Market
High Potency API Market by Type of Manufacturers [Value ($B) Shipment Analysis from 2017 to 2028]:
- Captive API Market
- Merchant API Market
High Potency API Market by Therapeutic Application [Value ($B) Shipment Analysis from 2017 to 2028]:
- Oncology
- Hormonal Imbalance
- Glaucoma
- Other therapeutic applications
High Potency API Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of High Potency API Companies
Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, high potency APIs companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the high potency APIs companies profiled in this report include-
- Pfizer
- F. Hoffmann-La Roche
- Sanofi
- Bristol-Myers Squibb
- Bayer AG
- Novartis International AG
- Boehringer Ingelheim International
- Teva Pharmaceutical Industries
- Eli Lilly and Company
- Merck & Co
- AbbVie
- Viatris
High Potency API Market Insights
- Lucintel forecasts that synthetic API is expected to remain the larger type of synthesis segment over the forecast period due to a growing number of new APIs and increasing adoption of these APIs in treating a wide range of diseases.
- Within this market, the oncology segment is expected to witness the highest growth over the forecast period due to increasing cases of cancer across the globe.
- North America is expected to remain the largest region over the forecast period due to growing incidence of chronic diseases and increased awareness of the high potency APIs in the treatment of serious ailments.
Features of the High Potency API Market
- Market Size Estimates: High potency API market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: High potency API market size by various segments, such as type, type of synthesis, type of manufacturers, therapeutic application, and region
- Regional Analysis: High potency API market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different types, applications, and regions for the high potency APIs market.
- Strategic Analysis: This includes M&A, new type development, and competitive landscape for the high potency APIs market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the high potency API market size?
Answer: The global high potency API market is expected to reach an estimated $38.1 billion by 2028.
Q2. What is the growth forecast for high potency API market?
Answer: The global high potency API market is expected grow with a CAGR of 8.7% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the high potency API market?
Answer: The major drivers for this market are growing demand for oncology drugs and antibody-drug conjugates, increasing demand for outsourcing HPAPIs, and growing focus on precision medicine.
Q4. What are the major segments for high potency API market?
Answer: The future of the high potency API market looks promising with opportunities in the oncology, glaucoma, hormonal imbalance, and other therapeutic applications segment.
Q5. Who are the key high potency APIs companies?
Answer: Some of the key high potency APIs companies are as follows:
Answer: The global high potency API market is expected to reach an estimated $38.1 billion by 2028.
Q2. What is the growth forecast for high potency API market?
Answer: The global high potency API market is expected grow with a CAGR of 8.7% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the high potency API market?
Answer: The major drivers for this market are growing demand for oncology drugs and antibody-drug conjugates, increasing demand for outsourcing HPAPIs, and growing focus on precision medicine.
Q4. What are the major segments for high potency API market?
Answer: The future of the high potency API market looks promising with opportunities in the oncology, glaucoma, hormonal imbalance, and other therapeutic applications segment.
Q5. Who are the key high potency APIs companies?
Answer: Some of the key high potency APIs companies are as follows:
- Pfizer
- F. Hoffmann-La Roche
- Sanofi
- Bristol-Myers Squibb
- Bayer AG
- Novartis International AG
- Boehringer Ingelheim International GmbH
- Teva Pharmaceutical Industries
- Eli Lilly and Company
- Merck & Co
- AbbVie
- Viatris
Q6. Which high potency APIs segment will be the largest in future?
Answer: Lucintel forecasts that synthetic APIs are expected to remain the larger segment over the forecast period due to growing number of new APIs and increasing adoption of these APIs in treating a wide range of diseases.
Q7. In high potency API market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest region over the forecast period due to growing incidence of chronic diseases and increased awareness of the high potency APIs in the treatment of serious ailments.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
